Alchemab Therapeutics Investor
Biotech companyВідповідно до джерел: 2Alchemab Therapeutics is a biotech company developing novel products for patients with diseases by harnessing naturally protective Therapeutics is a biotech company focused on discovering and developing novel therapeutics for patients with hard-to-treat diseases by harnessing the power of naturally protective Therapeutics -
Investors
Connections from
Founded Date:
2019.0
Estimated Revenue:
$12.7M
Headquarters:
Oxford, UK, London, Cambridge, the United States
Technology:
Biotechnology
Employee Number:
53